BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kardani K, Hashemi A, Bolhassani A. Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice. Molecular Immunology 2020;119:106-22. [DOI: 10.1016/j.molimm.2020.01.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Hasannejad-asl B, Pooresmaeil F, Takamoli S, Dabiri M, Bolhassani A. Cell penetrating peptide: A potent delivery system in vaccine development. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1072685] [Reference Citation Analysis]
2 Soltan MA, Abdulsahib WK, Amer M, Refaat AM, Bagalagel AA, Diri RM, Albogami S, Fayad E, Eid RA, Sharaf SMA, Elhady SS, Darwish KM, Eldeen MA. Mining of Marburg Virus Proteome for Designing an Epitope-Based Vaccine. Front Immunol 2022;13:907481. [DOI: 10.3389/fimmu.2022.907481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ullah N, Anwer F, Ishaq Z, Siddique A, Shah MA, Rahman M, Rahman A, Mao X, Jiang T, Lee BL, Bae T, Ali A. In silico designed Staphylococcus aureus B-cell multi-epitope vaccine did not elicit antibodies against target antigens suggesting multi-domain approach. J Immunol Methods 2022;:113264. [PMID: 35341759 DOI: 10.1016/j.jim.2022.113264] [Reference Citation Analysis]
4 Mugunthan SP, Mani Chandra H. A Computational Reverse Vaccinology Approach for the Design and Development of Multi-Epitopic Vaccine Against Avian Pathogen Mycoplasma gallisepticum. Front Vet Sci 2021;8:721061. [PMID: 34765664 DOI: 10.3389/fvets.2021.721061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Milani A, Baesi K, Agi E, Marouf G, Ahmadi M, Bolhassani A. HIV-1 Accessory Proteins: Which one is Potentially Effective in Diagnosis and Vaccine Development? Protein Pept Lett 2021;28:687-98. [PMID: 33390106 DOI: 10.2174/0929866528999201231213610] [Reference Citation Analysis]
6 Akbari E, Ajdari S, Mirabzadeh Ardakani E, Agi E, Khalaj V, Bolhassani A; 1Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran; 2Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran, Department of Immunology, Pasteur Institute of Iran, Tehran, Iran, Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran. Expression of a Novel HIV-1 Gag-Pol-Env-Nef-Rev Multi-Epitope Construct in Escherichia coli. JoMMID 2021;9:62-70. [DOI: 10.52547/jommid.9.2.62] [Reference Citation Analysis]
7 Kardani K, Basimi P, Fekri M, Bolhassani A. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Rev Clin Pharmacol 2020;13:1001-46. [PMID: 32838584 DOI: 10.1080/17512433.2020.1814743] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kardani K, Bolhassani A, Namvar A. An overview of in silico vaccine design against different pathogens and cancer. Expert Rev Vaccines 2020;19:699-726. [PMID: 32648830 DOI: 10.1080/14760584.2020.1794832] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
9 Jahedian S, Sadat SM, Javadi GR, Bolhassani A. Production and Evaluation of the Properties of HIV-1-Nef-MPER-V3 Fusion Protein Harboring IMT-P8 Cell Penetrating Peptide. Curr HIV Res 2020;18:315-23. [PMID: 32532193 DOI: 10.2174/1570162X18666200612151925] [Reference Citation Analysis]
10 Kardani K, Bolhassani A, Agi E, Hashemi A. B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs. Biotechnol Lett 2020;42:1847-63. [PMID: 32449070 DOI: 10.1007/s10529-020-02918-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]